Nobiletin alleviates atherosclerosis by inhibiting lipid uptake via the PPARG/CD36 pathway
Nobiletin alleviates atherosclerosis by inhibiting lipid uptake via the PPARG/CD36 pathway
About this item
Full title
Author / Creator
Wang, Heng , Tian, Qinqin , Zhang, Ruijing , Du, Qiujing , Hu, Jie , Gao, Tingting , Gao, Siqi , Fan, Keyi , Cheng, Xing , Yan, Sheng , Zheng, Guoping and Dong, Honglin
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Atherosclerosis (AS) is a persistent inflammatory condition triggered and exacerbated by several factors including lipid accumulation, endothelial dysfunction and macrophages infiltration. Nobiletin (NOB) has been reported to alleviate atherosclerosis; however, the underlying mechanism remains incompletely understood.
This study involved compreh...
Alternative Titles
Full title
Nobiletin alleviates atherosclerosis by inhibiting lipid uptake via the PPARG/CD36 pathway
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_671765ce9d4646098c629215964975f5
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_671765ce9d4646098c629215964975f5
Other Identifiers
ISSN
1476-511X
E-ISSN
1476-511X
DOI
10.1186/s12944-024-02049-5
